Approval · Notice of Compliance 341 · 2002

ANAFRANIL: Notice of Compliance 341

Issued October 15, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 341
Date: October 15, 2002
Company: Oryx Pharmaceuticals Inc.
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Antidepressant, antiobsessional

Products in this notice

Brand	DIN	Status today
ANAFRANIL	00330566	Marketed
ANAFRANIL	00324019	Marketed
ANAFRANIL	00402591	Marketed

Medicinal ingredients

CLOMIPRAMINE HCL 10 MG per TAB
CLOMIPRAMINE HCL 25 MG per TAB
CLOMIPRAMINE HCL 50 MG per TAB